phosphatidylcholines has been researched along with Osteoarthritis, Knee in 6 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (16.67) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 5 (83.33) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Liu, M; Martel-Pelletier, J; Pelletier, JP; Rahman, P; Randell, EW; Zhai, G | 1 |
| Aitken, D; Jones, G; Liu, M; Martel-Pelletier, J; Pelletier, JP; Rahman, P; Randell, E; Zhai, G | 1 |
| Aitken, D; Furey, A; Jones, G; Likhodii, S; Liu, M; Martin, G; Rahman, P; Randell, E; Sun, G; Zhai, G; Zhang, W | 1 |
| Appendino, G; Belcaro, G; Cesarone, MR; Dugall, M; Grossi, MG; Ledda, A; Pellegrini, L; Togni, S | 2 |
| Anderson, K; Grace, D; Rogers, J; Skeith, K | 1 |
4 trial(s) available for phosphatidylcholines and Osteoarthritis, Knee
| Article | Year |
|---|---|
Serum lysophosphatidylcholines to phosphatidylcholines ratio is associated with symptomatic responders to symptomatic drugs in knee osteoarthritis patients.
Topics: Aged; Anti-Inflammatory Agents, Non-Steroidal; Biomarkers; Cyclooxygenase Inhibitors; Female; Humans; Lysophosphatidylcholines; Male; Middle Aged; Naproxen; Osteoarthritis, Knee; Phosphatidylcholines; Pyrroles; Treatment Outcome | 2019 |
Product-evaluation registry of Meriva®, a curcumin-phosphatidylcholine complex, for the complementary management of osteoarthritis.
Topics: Adult; C-Reactive Protein; Curcumin; Drug Synergism; Edema; Female; Glycine max; Humans; Inflammation; Male; Middle Aged; Osteoarthritis, Knee; Phosphatidylcholines; Treatment Outcome; Walking | 2010 |
Efficacy and safety of Meriva®, a curcumin-phosphatidylcholine complex, during extended administration in osteoarthritis patients.
Topics: Aged; Analysis of Variance; Anti-Inflammatory Agents, Non-Steroidal; Antioxidants; Curcumin; Dose-Response Relationship, Drug; Exercise Tolerance; Female; Humans; Male; Middle Aged; Osteoarthritis, Knee; Pain Measurement; Phosphatidylcholines; Severity of Illness Index; Treatment Outcome; Walking | 2010 |
Topical diclofenac versus placebo: a double blind, randomized clinical trial in patients with osteoarthritis of the knee.
Topics: Administration, Topical; Aged; Anti-Inflammatory Agents, Non-Steroidal; Diclofenac; Double-Blind Method; Drug Compounding; Female; Humans; Knee Joint; Male; Middle Aged; Osteoarthritis, Knee; Phosphatidylcholines; Placebos; Severity of Illness Index; Treatment Outcome | 1999 |
2 other study(ies) available for phosphatidylcholines and Osteoarthritis, Knee
| Article | Year |
|---|---|
Activation of The Phosphatidylcholine to Lysophosphatidylcholine Pathway Is Associated with Osteoarthritis Knee Cartilage Volume Loss Over Time.
Topics: Cartilage Oligomeric Matrix Protein; Cartilage, Articular; Case-Control Studies; Disease Progression; Female; Humans; Knee Joint; Lysophosphatidylcholines; Male; Matrix Metalloproteinase 1; Middle Aged; Osteoarthritis, Knee; Phosphatidylcholines; Synovial Membrane | 2019 |
Lysophosphatidylcholines to phosphatidylcholines ratio predicts advanced knee osteoarthritis.
Topics: Aged; Arthroplasty, Replacement, Knee; Biomarkers; Cross-Sectional Studies; Female; Humans; Longitudinal Studies; Lysophosphatidylcholines; Male; Middle Aged; Newfoundland and Labrador; Osteoarthritis, Knee; Phosphatidylcholines; Prospective Studies; Tasmania | 2016 |